Jyothy Labs Schedules Q2 FY27 Results Conference Call for 4 November 2026
Last Updated: 14th October 2026 - 12:50 pm
Key Takeaways
- Jyothy Labs Limited has scheduled its Q2 FY27 analyst and investor conference call for 4 November 2026 at 4 PM IST.
- Management will discuss the unaudited financial results for the quarter and half-year ended 30 September 2026.
- The company announced the conference call through a regulatory filing submitted to the NSE and BSE on 14 October 2026.
Jyothy Labs Limited will hold an analyst and investor conference call on Wednesday, 4 November 2026, at 4 PM IST to discuss its financial performance for the second quarter of FY27.
The consumer products company informed the stock exchanges about the scheduled interaction on 14 October 2026.
The meeting will follow the declaration of its unaudited financial results for the quarter and half-year ended 30 September 2026.
Jyothy Labs has not disclosed its Q2 FY27 revenue, profit or other financial results in the conference call announcement.
Jyothy Labs Q2 FY27 Earnings Call Details
The conference call will provide an opportunity for analysts and investors to hear management discuss the company's performance during the July-September 2026 quarter.
The formal exchange communication also states that the discussion will address the company's direction following the financial results.
The scheduled details are:
| Particulars | Details |
|---|---|
| Company | Jyothy Labs Limited |
| Reporting Period | Q2 FY27 |
| Quarter Ended | 30 September 2026 |
| Results Covered | Quarter and half-year |
| Conference Call Date | 4 November 2026 |
| Time | 4 PM IST |
| NSE Symbol | JYOTHYLAB |
| BSE Code | 532926 |
The conference call will take place after the announcement of the relevant unaudited results. The filing does not specify a separate date or time for the results announcement.
How to Join the Jyothy Labs Earnings Call
The company has provided domestic dial-in numbers for the scheduled interaction.
Participants joining from India may use either +91 22 6280 1144 or +91 22 7115 8045.
International toll-free access is also available for participants in Singapore, Hong Kong, the United Kingdom and the United States.
The company has included a Diamond Pass registration option in its conference call invitation.
Details of the meeting and participation arrangements are available through Jyothy Labs' official corporate website.
What Will Be Discussed in the Results Call?
The primary purpose of the meeting is to review the company's unaudited financial results for the September 2026 quarter and the first six months of FY27.
Quarterly earnings discussions commonly address revenue performance, operating expenses, margins and business developments. However, the exact financial metrics and operational subjects that Jyothy Labs management will discuss have not yet been provided in the announcement.
Any management comments on future business conditions would need to be assessed separately from the reported financial results.
The exchange notification is therefore a scheduling disclosure. It should not be treated as a preview of the company's earnings performance.
Regulatory Disclosure Under SEBI LODR
Jyothy Labs submitted the conference call intimation under Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The communication was addressed to both the National Stock Exchange and BSE.
Shreyas Trivedi, Head of Legal and Company Secretary, signed the filing on behalf of the company.
By notifying the exchanges in advance, Jyothy Labs has made the timing of its planned investor interaction publicly available.
The company's Q2 FY27 financial figures will become available when the unaudited results are formally disclosed. Until then, the 14 October filing confirms the timing and purpose of the conference call, without providing any earnings numbers.
- Flat ₹20 Brokerage
- Next-gen Trading
- Advanced Charting
- Actionable Ideas
Trending on 5paisa
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.